GenScript now offers fast-track cGMP neoantigen peptide and peptide active pharmaceutical ingredients (API) from its new life-sciences manufacturing facility in Zhenjiang, leveraging its long ...

International contract research organization (CRO) GenScript Corporation has added a set of peptide library screening tools to its peptide-based drug development platform. These protocols are suitable ...

Piscataway-headquartered GenScript Biotech Corp. has expanded its research capabilities overseas with a new life sciences facility in China.

GenScript, a biotechnology company, has announced the commercial launch of its neoantigen peptide synthesis service for biotech and pharma companies developing personalized cancer therapeutics. The ...

GenScript’s neoantigen peptide synthesis platform is unique in that we begin every project with an assessment of each peptide’s sequence using our propriety NeoPre TM algorithm. This algorithm will ...

GenScript is recognized as having built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, peptide synthesis, custom antibody, and protein ...

This product profile describes the peptide libraries containing large varieties of peptides used for target screening in research areas.

About GenScript GenScript is a global biotechnology group providing gene, peptide, protein, CRISPR, and antibodies to scientists in more than 100 countries.

As a result, GenScript has built a best-in-class capacity and capability for biological research services, encompassing gene synthesis, mRNA synthesis, peptide synthesis, custom antibody generation, ...